Hatem Abdallah Ellaithy, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia, Ventilator-Associated | 2 | 2022 | 278 | 0.600 |
Why?
|
| DNA | 5 | 2019 | 7233 | 0.540 |
Why?
|
| DNA, Catenated | 2 | 2015 | 3 | 0.530 |
Why?
|
| Wounds, Gunshot | 2 | 2021 | 581 | 0.480 |
Why?
|
| Firearms | 2 | 2021 | 625 | 0.430 |
Why?
|
| Uterine Artery Embolization | 1 | 2020 | 59 | 0.340 |
Why?
|
| Nucleic Acid Conformation | 6 | 2019 | 899 | 0.320 |
Why?
|
| Trioxsalen | 1 | 2016 | 2 | 0.280 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 707 | 0.250 |
Why?
|
| Leiomyoma | 1 | 2020 | 654 | 0.250 |
Why?
|
| Crystallography, X-Ray | 2 | 2017 | 1982 | 0.250 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 1007 | 0.230 |
Why?
|
| Mastectomy, Segmental | 1 | 2019 | 972 | 0.230 |
Why?
|
| Nanotechnology | 2 | 2016 | 709 | 0.220 |
Why?
|
| Cross-Linking Reagents | 1 | 2016 | 685 | 0.210 |
Why?
|
| Urban Population | 1 | 2020 | 2022 | 0.200 |
Why?
|
| Crystallization | 3 | 2019 | 533 | 0.200 |
Why?
|
| Critical Illness | 2 | 2022 | 2709 | 0.190 |
Why?
|
| Uterine Neoplasms | 1 | 2020 | 1439 | 0.190 |
Why?
|
| Nanostructures | 1 | 2015 | 547 | 0.180 |
Why?
|
| Ventilators, Mechanical | 2 | 2022 | 287 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 3340 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3775 | 0.140 |
Why?
|
| Models, Molecular | 4 | 2017 | 5434 | 0.130 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2015 | 108 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4048 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 4591 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9276 | 0.090 |
Why?
|
| Pandemics | 1 | 2020 | 8624 | 0.090 |
Why?
|
| Suction | 1 | 2021 | 263 | 0.080 |
Why?
|
| Philadelphia | 1 | 2020 | 265 | 0.080 |
Why?
|
| Respiratory System | 1 | 2022 | 557 | 0.080 |
Why?
|
| X-Ray Diffraction | 1 | 2019 | 421 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 1006 | 0.080 |
Why?
|
| Thermodynamics | 1 | 2019 | 599 | 0.070 |
Why?
|
| Bromine | 1 | 2016 | 23 | 0.070 |
Why?
|
| Surface Properties | 1 | 2019 | 1161 | 0.070 |
Why?
|
| Photochemical Processes | 1 | 2016 | 86 | 0.070 |
Why?
|
| Microscopy, Atomic Force | 1 | 2016 | 247 | 0.060 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2015 | 110 | 0.060 |
Why?
|
| Base Pairing | 1 | 2015 | 140 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2015 | 291 | 0.060 |
Why?
|
| Trauma Centers | 1 | 2020 | 933 | 0.060 |
Why?
|
| Particle Size | 1 | 2019 | 1644 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 2061 | 0.060 |
Why?
|
| Carnivora | 1 | 1993 | 25 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2019 | 1791 | 0.060 |
Why?
|
| Physician's Role | 1 | 2021 | 918 | 0.060 |
Why?
|
| Observer Variation | 1 | 2020 | 2601 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 929 | 0.060 |
Why?
|
| Nucleotides | 1 | 2016 | 450 | 0.060 |
Why?
|
| Rabies | 1 | 1993 | 53 | 0.060 |
Why?
|
| Chest Pain | 1 | 2020 | 1106 | 0.060 |
Why?
|
| Fatigue | 1 | 2020 | 1544 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2015 | 4219 | 0.050 |
Why?
|
| Dyspnea | 1 | 2020 | 1352 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36290 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21025 | 0.050 |
Why?
|
| Gold | 1 | 2015 | 484 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2502 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2622 | 0.040 |
Why?
|
| Temperature | 1 | 2016 | 2221 | 0.040 |
Why?
|
| Reoperation | 1 | 2019 | 4291 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6828 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 8482 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8552 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3736 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80372 | 0.040 |
Why?
|
| Base Sequence | 1 | 2017 | 12446 | 0.030 |
Why?
|
| Humans | 7 | 2022 | 760621 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15289 | 0.030 |
Why?
|
| United States | 2 | 2021 | 72461 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 21392 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20080 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 219994 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 220352 | 0.020 |
Why?
|
| Vaccination | 1 | 1993 | 3361 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25942 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 40165 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 169152 | 0.020 |
Why?
|
| Female | 3 | 2020 | 391270 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58995 | 0.010 |
Why?
|
| Rabies Vaccines | 1 | 1993 | 27 | 0.010 |
Why?
|
| Zimbabwe | 1 | 1993 | 135 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65017 | 0.010 |
Why?
|
| Male | 2 | 2020 | 359744 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1993 | 4035 | 0.010 |
Why?
|
| Animals | 1 | 1993 | 167963 | 0.000 |
Why?
|